For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $0.74 in the prior trading day, GT Biopharma Inc (NASDAQ: GTBP) closed at $0.72, down -2.37%. In other words, the price has decreased by -$2.37 from its previous closing price. On the day, 0.76 million shares were traded. GTBP stock price reached its highest trading level at $0.75 during the session, while it also had its lowest trading level at $0.66.
Ratios:
Our goal is to gain a better understanding of GTBP by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.76 and its Current Ratio is at 2.76. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, ROTH MKM on December 02, 2024, initiated with a Buy rating and assigned the stock a target price of $11.
On May 24, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.
On April 13, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $21.B. Riley Securities initiated its Buy rating on April 13, 2021, with a $21 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GTBP now has a Market Capitalization of 2594826 and an Enterprise Value of -709598.
Stock Price History:
The Beta on a monthly basis for GTBP is 1.33, which has changed by -0.64 over the last 52 weeks, in comparison to a change of 0.13724327 over the same period for the S&P500. Over the past 52 weeks, GTBP has reached a high of $4.10, while it has fallen to a 52-week low of $0.55. The 50-Day Moving Average of the stock is -28.85%, while the 200-Day Moving Average is calculated to be -65.42%.
Shares Statistics:
The stock has traded on average 1.51M shares per day over the past 3-months and 8255900 shares per day over the last 10 days, according to various share statistics. A total of 3.27M shares are outstanding, with a floating share count of 3.10M. Insiders hold about 12.92% of the company’s shares, while institutions hold 9.80% stake in the company. Shares short for GTBP as of 1759190400 were 244248 with a Short Ratio of 0.16, compared to 1756425600 on 183043. Therefore, it implies a Short% of Shares Outstanding of 244248 and a Short% of Float of 6.94.
Earnings Estimates
The company has 1.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.21 and low estimates of -$0.21.
Analysts are recommending an EPS of between -$1.31 and -$1.31 for the fiscal current year, implying an average EPS of -$1.31. EPS for the following year is -$0.62, with 1.0 analysts recommending between -$0.62 and -$0.62.
